Total income during the July-September quarter of the current fiscal dipped marginally to Rs 1,800.45 crore
Total income up 11% to Rs 1,332 cr; exports grow by 39%
Integrated metal production was 2,10,000 tonnes for the quarter, almost flat from a year ago
Net profit stood at Rs 3,012 crore, as against Rs 945 crore for Q2FY19
Drug firm Jubilant Life Sciences on Friday reported a 18.88 per cent rise in consolidated net profit at Rs 249.39 crore for the quarter ended September 30, 2019. The company said its board has also approved demerger of the Life Science Ingredients business. Jubilant Life had posted a net profit of Rs 209.77 crore in the corresponding July-September period of the previous fiscal, it said in a filing to the BSE. Consolidated total revenue from operations stood at Rs 2,265.93 crore for the quarter under consideration as against Rs 2,269.49 crore in the same period a year ago. "We witnessed steady performance in revenue and improvement in operating profits in Q2'FY20 both on a YoY basis and sequentially," Jubilant Life Sciences Chairman Shyam S Bhartia and Co-Chairman & MD Hari S Bhartia said. The board of the company has approved the recommendations of a committee constituted to consider the option of reorganising the businesses of the company. The board has given go-ahead to ...
Firm provides nearly Rs 25 crore on Essel group debentures in books
ITC pointed to some measures as having helped it get over the muted demand in the markets
Led by volumes, net sales rose 9.4 per cent and Ebitda margin was up 60 bps in Q2; earnings visibility still looks strong, say analysts
The bank suffered a net loss of Rs 112 crore for the quarter due to a Rs 2,138-crore one-off deferred tax asset
The bank had registered a net profit of Rs 27 crore in July-September quarter of the previous financial year
The weakest quarterly performance by the bank since listing saw gross NPA ratio at 2.6 per cent breach the management guidance provided earlier
The fourth Crisidex survey, jointly undertaken by Crisil and Sidbi, said lenders' sentiment has also increased since the last survey
The review for Q2 of FY18 is good with improvement in H2FY18 & beyond